Cure My Disease

Don't miss your cure!

 Log in / Sign up

New blood clot test could speed up care for heart patients

NCT ID NCT07382076

Diagnosis Sponsor: Abbott Point of Care Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study evaluates a new cartridge (i-STAT ACTpro) that measures how long it takes for blood to clot in adults who are given heparin to prevent clots during medical procedures. Researchers will compare the results from this new test with those from a standard device to see if it works just as well. About 500 adults will take part, and the goal is to make clotting time checks faster and easier.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

500 people

The number who actually took part.

Started

Dec 2023

Expected to finish

Mar 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults undergoing procedures where venous and arterial whole blood specimens are obtained in different care settings.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subject is prescribed unfractionated heparin (UFH) peri-procedurally in order to reduce the risk of blood clots. OR \- Subject for which only the baseline specimen (prior to UFH administration) is collected, subject is admitted for a medical procedure that would or could typically necessitate the use of UFH to reduce the risk of blood clots. Exclusion Criteria: * Prior enrollment in the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Activated clotting time are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Activated clotting time

Contacts and locations

Locations

  • Dignity Health Chandler Regional Medical Center

    Chandler, Arizona, 85224, United States

  • Eastside Research Associates - Redmond

    Redmond, Washington, 98052, United States

  • George Washington University

    Washington D.C., District of Columbia, 20052, United States

  • Icahn School of Medicine at Mount Sinai

    New York, New York, 10029, United States

  • Kentucky Clinical Trials Laboratory

    Louisville, Kentucky, 40202, United States

  • Minneapolis Heart Institute

    Minneapolis, Minnesota, 55407, United States

  • Penn State University Hershey Medical Center

    Hershey, Pennsylvania, 17033, United States

  • Thomas Jefferson University

    Philadelphia, Pennsylvania, 19107, United States

  • University of California at San Francisco

    San Francisco, California, 94132, United States

  • University of Maryland

    Baltimore, Maryland, 21201, United States

  • Washington University

    St Louis, Missouri, 63110, United States